Scinai Immunotherapeutics (SCNI) Cash & Equivalents (2015 - 2026)
Scinai Immunotherapeutics' Cash & Equivalents was $2.65 million in Q2 2026, up 134.7% from $1.13 million a year earlier but down 10.4% from the prior quarter.
Powered by 
Analysis
Scinai Immunotherapeutics (SCNI) Cash & Equivalents (2015 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Scinai Immunotherapeutics came in at $1.66 million, down 15.4% from FY2024.
- Cash & Equivalents has now declined for three consecutive years, with a five-year compound annual growth rate of -53.0% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $1.96 million in FY2024 (-86.2%), $14.22 million in FY2023 (-18.9%), $17.52 million in FY2022 (unchanged) and $17.52 million in FY2021 (-75.8%).
- Quarterly Cash & Equivalents has moved between $1.03 million (Q3 2024) and $17.52 million (Q3 2022) over five years.
- Compared with a year earlier, Cash & Equivalents was higher in 1 of the last five quarters, with an average decline of 19.6%.
- The best year-over-year quarter for Cash & Equivalents over five years was Q4 2021 (growth of 473.6%); the worst was Q3 2024 (a decline of 92.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.61 Bn | 1,101.20 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.68 Bn | 555.54 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 506.54 Bn | 479.65 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.37 Bn | 312.75 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 292.65 Bn | 256.64 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.69 Bn | 239.37 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.83 Bn | 193.23 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 195.33 Bn | 169.52 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.37 Bn | 118.01 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Scinai Immunotherapeutics | 133,087.32 | -8.13 Mn | -1.25 Mn | 2.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.65 Mn |
| Mar 31, 2026 | 2.96 Mn |
| Dec 31, 2025 | 1.66 Mn |
| Jun 30, 2025 | 989,000.00 |
| Dec 31, 2024 | 1.96 Mn |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 3.08 Mn |
| Mar 31, 2024 | 4.83 Mn |
| Dec 31, 2023 | 4.87 Mn |
| Sep 30, 2023 | 6.36 Mn |
| Jun 30, 2023 | 7.51 Mn |
| Mar 31, 2023 | 10.80 Mn |
| Dec 31, 2022 | 14.08 Mn |
| Sep 30, 2022 | 8.31 Mn |
| Jun 30, 2022 | 11.29 Mn |
| Mar 31, 2022 | 15.39 Mn |
| Dec 31, 2021 | 17.41 Mn |
| Sep 30, 2021 | 10.74 Mn |
| Jun 30, 2021 | 12.26 Mn |
| Dec 31, 2020 | 2.93 Mn |
API Access
Scinai Immunotherapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SCNI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "SCNI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SCNI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();